← Back to team
Yossi BenAmram

Yossi BenAmram

Co-founder, Chief Strategy and Operations Officer

Former SVP and President of the EURAM region at MSD, with more than 35 years in the pharmaceutical industry.

LinkedIn profile

Biography

Yossi BenAmram co-founded Golden Age Health in 2023 and leads its strategy and operations across Greater China, Southeast Asia and the Gulf. He works with partners in the United States, Europe and China to bring approved and near-approved rare and specialty medicines to patients in markets they cannot serve efficiently on their own.

Yossi spent more than 20 years at MSD (Merck and Co.). As SVP and President of the EURAM region (Europe, Russia, Africa and the Middle East), he led the regional launch of Keytruda and took MSD from fifth to first position in pharmaceutical sales in the region. He also served as President of the Mid Europe region and as President of the Diversified Brands division, a global portfolio of established medicines later carved out as Organon.

His earlier roles at MSD included Head of Operations for Emerging Markets, Vice President and Global Brand Leader for the respiratory franchise, and Managing Director of MSD Israel. He began his career at Teva, where he spent nearly a decade.

“Western biotechs build important rare disease medicines. Too often, patients in Greater China, Southeast Asia and the Gulf never see them.”

Yossi BenAmram

Board and advisory roles

  • PolyPid (NASDAQ: PYPD), Independent Director (since 2023)
  • PharOS, Board Member (since 2024)
  • Interna Therapeutics, Senior Business Advisor
  • Armira, Senior Investment Advisor

Education

  • MBA, Tel Aviv University